Lisa Wipperman Heine's most recent trade in Surmodics, Inc. was a trade of 2,640 Common Stock done at an average price of $27.3 . Disclosure was reported to the exchange on Feb. 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Surmodics, Inc. | Lisa Wipperman Heine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.30 per share. | 18 Feb 2025 | 2,640 | 16,093 (0%) | 0% | 27.3 | 72,072 | Common Stock |
Surmodics, Inc. | Lisa Wipperman Heine | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,640 | 0 | - | - | Stock Option (right to buy) | |
Surmodics, Inc. | Lisa Wipperman Heine | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.09 per share. | 18 Feb 2025 | 2,115 | 13,978 (0%) | 0% | 34.1 | 72,100 | Common Stock |
Surmodics, Inc. | Lisa Heine Wipperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 3,853 | 3,853 | - | - | Stock Option (right to buy) | |
Surmodics, Inc. | Heine Lisa Wipperman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,803 | 13,453 (0%) | 0% | 0 | Common Stock | |
Miromatrix Medical Inc | Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 54,201 | 134,356 | - | 0 | Common Stock | |
Miromatrix Medical Inc | Lisa Wipperman Heine | Director | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 10 Mar 2023 | 31,250 | 80,155 | - | 1.6 | 50,000 | Common Stock |
Surmodics, Inc. | Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 4,674 | 4,674 | - | - | Stock Option (right to buy) | |
Surmodics, Inc. | Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 1,984 | 11,650 (0%) | 0% | 0 | Common Stock | |
Miromatrix Medical Inc | Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 12,788 | 48,905 | - | 0 | Common Stock | |
Surmodics, Inc. | Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 3,555 | 3,555 | - | - | Stock Option (right to buy) | |
Surmodics, Inc. | Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 1,375 | 9,666 (0%) | 0% | 0 | Common Stock | |
Surmodics, Inc. | Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 2,964 | 2,964 | - | - | Stock Option (right to buy) | |
Surmodics, Inc. | Lisa Wipperman Heine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 1,067 | 8,291 (0%) | 0% | 0 | Common Stock |